Sugai M, Amino Y, Fujishima S, Nibuya K, et al. Impact of immune-related adverse event severity on overall survival in patients with advanced NSCLC receiving immune checkpoint inhibitors therapy, with a focus on combination regimens. Lung Cancer 2025;204:108555.
PMID: 40311310